G Hessler, KH Baringhaus - Molecules, 2018 - mdpi.com
… of artificialintelligence in the field of property or activity prediction, de novo design and … systems has been largely increased over recent years, now also comprising de novo design or …
W Duch, K Swaminathan… - … pharmaceutical design, 2007 - ingentaconnect.com
… , machinelearning and artificialintelligence approaches play an increasingly important role in rational drugdesign, … role of machinelearning and artificialintelligence approaches in …
… design. Nevertheless, extravagant claims have been made for the ability of ArtificialIntelligence (AI) to accelerate the design … on whether novel artificialintelligence methods contribute …
… , eg, for small molecule drug research and development. In this … applications in small molecule drugdesign; and briefly introduced how … for small molecule drugdesign and development. …
Y Zhang, M Luo, P Wu, S Wu, TY Lee, C Bai - International journal of …, 2022 - mdpi.com
… Traditional drugdesign requires a great amount of research time and developmental … -aided drugdesign, and artificialintelligence, have the potential to expedite the efficiency of drug …
AA Arabi - Future Drug Discovery, 2021 - Taylor & Francis
… drugs is rapidly growing due to advances in machinelearning (ML) and artificialintelligence … This review covers myriad faces of AI and ML in drugdesign. There is a plethora of AI …
… drugs. These AI and ML methods are applied in every step of the computer-aided drugdesign, and … drugdesign, along with its challenge and opportunity for the pharmaceutical industry. …
… use of artificialintelligence (AI) systems in drugdesign. Neural … run SciPy or NumPy packages included in drugdesign tools. … recent developments in the field of drugdesign based on AI. …
… medicine and two-dimensional ligand design. The three-dimensional (… drugdesign by deep learning. Here, the MolAICal software is introduced to supply a way for generating 3D drugs …